ArticleActa veterinaria Scandinavica2026
Congenital urethral sphincter mechanism incompetence: observational clinical findings and treatment outcomes-a small retrospective study in 19 bitches.
Article in Acta veterinaria Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to report observational clinical findings and treatment outcomes in a population of bitches affected with congenital urethral sphincter mechanism incompetence (CUSMI). Response rate to sympaticomimetic drugs has not yet been reported in the literature in dogs affected with CUSMI. Juvenile bitches showing clinical signs of urinary incontinence were included. A diagnosis of CUSMI was made based on history, clinical signs, confirmation of orthotopic ureters and urethral pressure profilometry. At first consultation, all bitches (neutered or not) received phenylpropanolamine 1.5 mg/kg orally Semel in Die for at least one month. Median short-term (32 days) and long-term (38.7 months) follow-up data were collected via physical recheck, telephone or email questionnaire with owners, to include continence scores.
resultsNineteen bitches met the inclusion criteria. At the time of diagnosis, there was no significant difference of continence score between neutered and non-neutered bitches (P = 0.14). During the course of the study, 17 out of 19 bitches were neutered: nine were neutered before the first heat (before heat group) and eight after the first heat (after heat group). Two bitches were non neutered at long term follow-up. After phenylpropanolamine treatment, continence score was not significantly different between the two groups (P = 0.71) with a median continence score of 4 (2-5) for the before heat group and a median continence score of 4 (3-5) for the after heat group. 26% of bitches (5/19) were fully continent after phenylpropanolamine treatment at short term follow-up. Continence score after treatment (median = 4 [2-5]) was significantly higher than continence score at diagnosis (median = 2 [1-4]) (P < 0.001). In the after heat group, temporary improvement of continence scores was observed before or during estrus in three out of eight dogs. Worsening of continence score was reported after neutering in 5/17 dogs. At long-term follow-up, 6/19 dogs were fully continent, 5 of them receiving additional treatment.
conclusionBased on the results of this retrospective study, CUSMI may show a low rate of initial complete response achieving full continence status after phenylpropanolamine treatment at 1.5 mg/kg SID orally when compared to treatment of acquired urethral sphincter mechanism incompetence patients. Observational clinical findings suggest that worsening of incontinence may possibly occur after neutering including dogs that experienced improvement before or during estrus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.